Bessemer Venture Partners (BVP) is one of the oldest and largest venture capital firms in the world, founded in 1911 and headquartered in Redwood City. It invests across AI, biotech, cloud, consumer, healthcare, and deep tech with a global portfolio of 900+ companies including 74 unicorns and 150+ IPOs. Within healthcare and biotech, BVP invests from seed through growth stage.

While not a dedicated neurotech fund, BVP's broad healthcare mandate and its scale mean it participates selectively in neurotech-adjacent companies. Notable relevant investments include Abridge (AI-powered clinical documentation with healthcare delivery implications). BVP is most relevant for neurotech companies with strong software/AI components or scalable digital health platforms rather than pure device plays.